Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_assertion type Assertion NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_head.
- NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_assertion description "[GEP-defined high-risk designation, pertinent to 17% of patients, imparted inferior OS, EFS, and CRD in both protocols and, on multivariate analysis, was the sole adverse feature affecting OS, EFS, and CRD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_provenance.
- NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_assertion evidence source_evidence_literature NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_provenance.
- NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_assertion SIO_000772 20124509 NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_provenance.
- NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_assertion wasDerivedFrom befree-20140225 NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_provenance.
- NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_assertion wasGeneratedBy ECO_0000203 NP764529.RAgnMo6I1p5s1eWfrR7d9dsWgOIPBxuZ1we4JHg0esNwM130_provenance.